| 1 Visual inspection ‐ in‐person (invasive melanoma) |
2 |
147 |
| 2 VI+dermoscopy ‐ in‐person (invasive melanoma) |
6 |
789 |
| 3 Visual inspection ‐ image‐based (invasive melanoma) |
4 |
454 |
| 4 Dermoscopy alone ‐ image‐based (invasive melanoma) |
13 |
5618 |
| 5 Visual inspection ‐ in‐person (invasive melanoma or atypical intraepidermal melanocytic variants) |
13 |
6740 |
| 6 VI+dermoscopy ‐ in‐person (invasive melanoma or atypical intraepidermal melanocytic variants) |
26 |
23169 |
| 7 Visual inspection ‐ image‐based (invasive melanoma or atypical intraepidermal melanocytic variants) |
11 |
1740 |
| 8 Dermoscopy alone ‐ image‐based (invasive melanoma or atypical intraepidermal melanocytic variants) |
60 |
13475 |
| 9 Visual inspection ‐ in‐person (any) |
2 |
3457 |
| 10 VI+Dermoscopy ‐ in‐person (Any) |
4 |
3880 |
| 11 Visual inspection ‐ image‐based (any) |
3 |
547 |
| 12 Dermoscopy alone ‐ image‐based (any) |
5 |
815 |
| 13 MM2‐ Dermoscopy ‐ no algorithm ‐ threshold NR ‐ in‐person |
8 |
4707 |
| 14 MM2‐ Dermoscopy ‐ pattern ‐ at ≥ 1 char present ‐ in‐person |
1 |
220 |
| 15 MM2‐ Dermoscopy ‐ pattern ‐ at ≥ 3 characteristics present ‐ in‐person |
1 |
68 |
| 16 MM2‐ Dermoscopy ‐ pattern ‐ threshold NR ‐ in‐person |
6 |
4307 |
| 17 MM2‐ Dermoscopy ‐ ABCD at NR (likely > 5.45) ‐ in‐person |
1 |
235 |
| 18 MM2‐ Dermoscopy ‐ ABCD at > 5.45 ‐ in‐person |
4 |
1203 |
| 19 MM2‐ Dermoscopy ‐ ABCD at > 4.75 ‐ in‐person |
1 |
309 |
| 20 MM2‐ Dermoscopy ‐ ABCD at 60% specificity ‐ in‐person |
1 |
356 |
| 21 MM2‐ Dermoscopy ‐ ABCD at 80% specificity ‐ in‐person |
1 |
356 |
| 22 MM2‐ Dermoscopy ‐ ABCD at 70% specificity ‐ in‐person |
1 |
356 |
| 23 MM2‐ Dermoscopy ‐ ABCD at 75% specificity ‐ in‐person |
1 |
356 |
| 24 MM2‐ Dermoscopy ‐ ABCD at 85% specificity ‐ in‐person |
1 |
356 |
| 25 MM2‐ Dermoscopy ‐ ABCD at 90% specificity ‐ in‐person |
1 |
356 |
| 26 MM2‐ Dermoscopy ‐ ABCDE at > 1.3 ‐ in‐person |
1 |
356 |
| 27 MM2‐ Dermoscopy ‐ ABCDE at > 2.65 ‐ in‐person |
1 |
356 |
| 28 MM2‐ Dermoscopy ‐ ABCDE at > 3.05 ‐ in‐person |
1 |
356 |
| 29 MM2‐ Dermoscopy ‐ ABCDE at > 3.6 ‐ in‐person |
1 |
356 |
| 30 MM2‐ Dermoscopy ‐ ABCDE at > 4.25 ‐ in‐person |
1 |
356 |
| 31 MM2‐ Dermoscopy ‐ ABCDE at > 4.9 ‐ in‐person |
1 |
356 |
| 32 MM2‐ Dermoscopy ‐ 7FFM at ≥ 2 ‐ in‐person |
1 |
401 |
| 33 MM2‐ Dermoscopy ‐ 7‐point at ≥ 2 ‐ in‐person |
1 |
638 |
| 34 MM2‐ Dermoscopy ‐ 7‐point at ≥ 3 ‐ in‐person |
2 |
11137 |
| 35 MM2‐ Dermoscopy ‐ Menzies at 2 negative and ≥ 1 positive ‐ in‐person |
1 |
206 |
| 36 MM2‐ Dermoscopy ‐ no algorithm ‐ any threshold ‐ image‐based |
24 |
4498 |
| 37 MM2‐ Dermoscopy ‐ no algorithm ‐ correct diagnosis ‐ image‐based |
18 |
4118 |
| 38 MM2‐ Dermoscopy ‐ no algorithm ‐ excise decision ‐ image‐based |
10 |
831 |
| 39 MM2‐ Dermoscopy ‐ pattern ‐ any threshold ‐ image‐based |
20 |
4621 |
| 40 MM2‐ Dermoscopy ‐ pattern ‐ correct diagnosis ‐ image‐based |
19 |
4095 |
| 41 MM2‐ Dermoscopy ‐ pattern ‐ excise decision ‐ image‐based |
3 |
933 |
| 42 MM2‐ Dermoscopy ‐ ABCD at > 4.75 ‐ image‐based |
10 |
4242 |
| 43 MM2‐ Dermoscopy ‐ ABCD at > 5.45 ‐ image‐based |
7 |
2471 |
| 44 MM2‐ Dermoscopy ‐ revised ABCD at ≥ 4 ‐ image‐based |
1 |
269 |
| 45 MM2‐ Dermoscopy ‐ ABCDE at ≥ 4 ‐ image‐based |
1 |
269 |
| 46 MM2‐ Dermoscopy ‐ 7‐point at NR ‐ image‐based |
4 |
1936 |
| 47 MM2‐ Dermoscopy ‐ 7‐point at ≥ 3 ‐ image‐based |
11 |
3408 |
| 48 MM2‐ Dermoscopy ‐ 7‐point at ≥ 5 ‐ image‐based |
1 |
322 |
| 49 MM2‐ Dermoscopy ‐ revised 7‐point at NR (likely ≥ 1) ‐ image‐based |
1 |
1678 |
| 50 MM2‐ Dermoscopy – revised 7‐point at ≥ 1 ‐ image‐based |
1 |
300 |
| 51 MM2‐ Dermoscopy ‐ revised 7‐point for FU ‐ major change ‐ image‐based |
1 |
70 |
| 52 MM2‐ Dermoscopy ‐ 7FFM at ≥ 2 ‐ image‐based |
4 |
2200 |
| 53 MM2‐ Dermoscopy ‐ Menzies at 2 negative and ≥ 1 positive ‐ image‐based |
4 |
1856 |
| 54 MM2‐ Dermoscopy ‐ Menzies at NR ‐ image‐based |
2 |
60 |
| 55 MM2‐ Dermoscopy ‐ 3‐point at ≥ 2 ‐ image‐based |
7 |
1505 |
| 56 MM2‐ Dermoscopy ‐ 4‐point (scored 3‐point) at > 2 ‐ image‐based |
1 |
75 |
| 57 MM2‐ Dermoscopy ‐ Hofman algorithm at NR ‐ image‐based |
1 |
254 |
| 58 MM2‐ Dermoscopy CASH at ≥ 6 ‐ image‐based |
1 |
477 |
| 59 MM2‐ Dermoscopy CASH at ≥ 8 ‐ image‐based |
2 |
190 |
| 60 MM2‐ Dermoscopy Chaos/Clues at = 2 ‐ image‐based |
2 |
940 |
| 61 MM2‐ Dermoscopy ‐ Acral 3‐step ‐ image‐based |
1 |
107 |
| 62 VI+dermoscopy (in‐person) ‐ observer experience NR (invasive melanoma or atypical intraepidermal melanocytic variants) |
10 |
8390 |
| 63 VI+dermoscopy (in‐person) ‐ high experience (invasive melanoma or atypical intraepidermal melanocytic variants) |
14 |
14213 |
| 65 VI+dermoscopy (in‐person) ‐ trained observer (invasive melanoma or atypical intraepidermal melanocytic variants) |
2 |
566 |
| 66 Dermoscopy (image‐based) ‐ observer experience NR (invasive melanoma or atypical intraepidermal melanocytic variants) |
11 |
2777 |
| 67 Dermoscopy (image‐based) ‐ high experience (invasive melanoma or atypical intraepidermal melanocytic variants) |
34 |
8933 |
| 68 Dermoscopy (image‐based) ‐ moderate experience (invasive melanoma or atypical intraepidermal melanocytic variants) |
5 |
678 |
| 69 Dermoscopy (image‐based) ‐ low experience (invasive melanoma or atypical intraepidermal melanocytic variants) |
6 |
448 |
| 70 Dermoscopy (image‐based) ‐ mixed experience (invasive melanoma or atypical intraepidermal melanocytic variants) |
5 |
473 |
| 71 Dermoscopy (image‐based) ‐ trained observer (invasive melanoma or atypical intraepidermal melanocytic variants) |
11 |
1087 |
| 72 VI+dermoscopy (in‐person) ‐ consultant expert (invasive melanoma or atypical intraepidermal melanocytic variants) |
11 |
2767 |
| 73 VI+dermoscopy (in‐person) ‐ consultant (invasive melanoma or atypical intraepidermal melanocytic variants) |
10 |
8390 |
| 74 VI+dermoscopy (in‐person) ‐ resident/registrar (invasive melanoma or atypical intraepidermal melanocytic variants) |
2 |
11137 |
| 75 VI+dermoscopy (in‐person) ‐ mixed (secondary care‐based) (invasive melanoma or atypical intraepidermal melanocytic variants) |
1 |
309 |
| 76 VI+dermoscopy (in‐person) ‐ GP (invasive melanoma or atypical intraepidermal melanocytic variants) |
2 |
566 |
| 77 Dermoscopy (image‐based) ‐ consultant expert (invasive melanoma or atypical intraepidermal melanocytic variants) |
33 |
8664 |
| 78 Dermoscopy (image‐based) ‐ consultant (invasive melanoma or atypical intraepidermal melanocytic variants) |
24 |
3986 |
| 79 Dermoscopy (image‐based) ‐ resident (invasive melanoma or atypical intraepidermal melanocytic variants) |
5 |
927 |
| 80 Dermoscopy (image‐based) ‐ mixed (secondary care based) (invasive melanoma or atypical intraepidermal melanocytic variants) |
4 |
399 |
| 81 Dermoscopy (image‐based) ‐ mixed (other) (invasive melanoma or atypical intraepidermal melanocytic variants) |
4 |
867 |
| 82 Dermoscopy (image‐based) ‐ GP/primary care (invasive melanoma or atypical intraepidermal melanocytic variants) |
3 |
288 |
| 83 Dermoscopy (image‐based) ‐ physician assistant (invasive melanoma or atypical intraepidermal melanocytic variants) |
1 |
65 |
| 84 Dermoscopy ‐ before training (invasive melanoma or atypical intraepidermal melanocytic variants) |
4 |
245 |
| 85 Dermoscopy ‐ after training (invasive melanoma or atypical intraepidermal melanocytic variants) |
4 |
245 |
| 86 Dermoscopy ‐ before training (invasive melanoma) |
2 |
150 |
| 87 Dermoscopy ‐ after training (invasive melanoma) |
2 |
150 |
| 88 MM1‐ Dermoscopy ‐ no algorithm ‐ threshold NR ‐ in‐person |
3 |
190 |
| 89 MM1‐ Dermoscopy ‐ pattern analysis ‐ threshold NR ‐ in‐person |
1 |
45 |
| 90 MM1‐ Dermoscopy ‐ ABCD at > 4.2 ‐ in‐person |
1 |
495 |
| 91 MM1‐ Dermoscopy ‐ ABCD at > 5.45 ‐ in‐person |
2 |
832 |
| 92 MM1‐ Dermoscopy ‐ Kenet (modified) at melanoma possible ‐ in‐person |
1 |
54 |
| 93 MM1‐ Dermoscopy ‐ Kenet (modified) at melanoma likely ‐ in‐person |
1 |
54 |
| 94 MM1‐ Dermoscopy ‐ no algorithm ‐ threshold NR ‐ image‐based |
6 |
683 |
| 95 MM1‐ Dermoscopy ‐ no algorithm ‐ decision to excise ‐ image‐based (paired data only) |
1 |
99 |
| 96 MM1‐ Dermoscopy ‐ pattern analysis ‐ threshold NR ‐ image‐based |
1 |
119 |
| 97 MM1‐ Dermoscopy ‐ ABCD at > 4.75 ‐ image‐based |
2 |
330 |
| 98 MM1‐ Dermoscopy ‐ ABCD at > 5.45 ‐ image‐based |
1 |
258 |
| 99 MM1‐ Dermoscopy ‐ 7‐point at NR ‐ image‐based |
1 |
332 |
| 100 MM1‐ Dermoscopy ‐ Menzies at 2 negative and ≥ 1 positive ‐ image‐based |
4 |
4184 |
| 101 MM1‐ Dermoscopy ‐ 3‐point at > NR ‐ image‐based |
1 |
332 |
| 102 MM1‐ Dermoscopy ‐ Kenet at melanoma likely ‐ image‐based |
1 |
258 |
| 103 MM1‐ Dermoscopy ‐ Kenet at melanoma possible ‐ image‐based |
1 |
258 |
| 104 MM1‐ Dermoscopy CASH at ≥ 8 ‐ image‐based |
1 |
332 |
| 105 MM1‐ Dermoscopy ‐ Kreusch algorithm ‐ image‐based |
1 |
265 |
| 106 MM1‐ Dermoscopy ‐ Menzies for amelanotic at 1 ‐ image‐based |
1 |
332 |
| 107 MM1‐ Dermoscopy ‐ Menzies for amelanotic at 0 ‐ image‐based |
1 |
332 |
| 108 MM3‐ Dermoscopy – no algorithm at NR ‐ in‐person |
1 |
231 |
| 109 MM3‐ Dermoscopy ‐ pattern analysis ‐ threshold NR ‐ in‐person |
1 |
3372 |
| 110 MM3‐ Dermoscopy – ABCD at > 5.45 ‐ in‐person |
1 |
200 |
| 111 MM3‐ Dermoscopy – 3‐point at ≥ 2 ‐ in‐person |
1 |
77 |
| 112 MM3‐ Dermoscopy – no algorithm at NR ‐ image‐based |
2 |
83 |
| 113 MM3‐ Dermoscopy ‐ pattern analysis ‐ threshold NR ‐ image‐based |
1 |
119 |
| 114 MM3‐ Dermoscopy – 3‐point at ≥ 2 ‐ image‐based |
1 |
150 |
| 115 MM2 ‐ VI ‐ in‐person (with image‐based dermoscopy) |
2 |
886 |
